Agriculture Company Settles OFAC Charges For Violating Cuban Assets Control Regulations

CW
Cadwalader, Wickersham & Taft LLP

Contributor

Cadwalader, established in 1792, serves a diverse client base, including many of the world's leading financial institutions, funds and corporations. With offices in the United States and Europe, Cadwalader offers legal representation in antitrust, banking, corporate finance, corporate governance, executive compensation, financial restructuring, intellectual property, litigation, mergers and acquisitions, private equity, private wealth, real estate, regulation, securitization, structured finance, tax and white collar defense.
An animal nutrition company involved in the sales of agricultural commodities outside of the United States agreed to settle OFAC charges for violations of the Cuban Assets Control Regulations.
United States International Law

An animal nutrition company involved in the sales of agricultural commodities outside of the United States agreed to settle OFAC charges for violations of the Cuban Assets Control Regulations.

According to OFAC, the animal nutrition company, BIOMIN America, Inc., coordinated agricultural commodity sales to a Cuban company, resulting in 44 apparent violations. In particular, BIOMIN America allegedly routed the Cuba-related business through its foreign affiliates, developing "a transaction structure that it incorrectly determined would be consistent with U.S. sanctions requirements."

OFAC emphasized that the transactions at issue could have been conducted in a manner consistent with an existing general license, or the company could have applied for a specific license from OFAC. OFAC noted that sanctions violations frequently arise from a misinterpretation or lack of understanding of the agency's regulations, as was the case with respect to BIOMIN. OFAC advised companies subject to U.S. jurisdiction to maintain an appropriate sanctions compliance program, and to seek "appropriate advice and guidance" when contemplating business that may be impacted by U.S. sanctions programs.

In light of the fact that the transactions may have been eligible for authorization, as well as BIOMIN America's voluntary self-disclosure, compliance enhancements, and other factors, OFAC determined that the apparent violations constituted a "non-egregious" case, and agreed to a settlement amount of $257,862.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More